NCT00001354View on ClinicalTrials.gov

Interleukin-2 Therapy for HIV Infection - Supplemental Procedures

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 1993

Study Completion Date

March 31, 2002

Conditions
Acquired Immunodeficiency SyndromeHIV Infection
Interventions
DRUG

Interleukin-2/Zidovudine (AZT)

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001354 - Interleukin-2 Therapy for HIV Infection - Supplemental Procedures | Biotech Hunter | Biotech Hunter